Chloe Kirk, PhD
Science Correspondent
BiotechTV
Comm Convo
July 2026 Comm Convo: Why Only Some Platforms Are Trusted When Everyone Has One
The most trusted voice on any given biopharma issue is increasingly someone who does not report to communications. The 2026 Edelman Trust Barometer shows medical scientists and experts at 68% trust in the U.S., down 7 points from last year, while healthcare CEOs land at 27% and journalists sit barely above them at 28%. For senior communicators, this creates a genuinely complicated operating reality: we are building narratives and managing reputations in a landscape where a researcher’s independent Substack can carry more weight than a corporate press release, and where the most credible voice on a given issue may not sit in our department or report to anyone in our chain of command. This session brings together communications leaders to examine what the credibility shift means for how we identify, activate, and work alongside the voices our organizations need.
Why watch
- Reframe your spokesperson strategy around the scientific, clinical, and community voices your audiences already trust.
- Navigate the balance of developing employees and experts as credible communicators without creating brand, legal, or compliance risk.
- Rethink your channel architecture on where your messages earn trust, where they lose it, and why platform choice now carries as much weight for credibility as it does for reach.
- Pressure-test your assumptions about who speaks for your organization and when, as the gap between institutional authority and actual audience trust continues to grow.
